Skip to main content
Equibles
RDGL logo

RDGL · Vivos Inc · Documents

Track RDGL — free

Use RDGL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RDGL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.04 0.00 (-0.23%) At close · Nov 12
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The independent registered public accounting firm has expressed substantial doubt about the Company's ability to continue as a going concern due to limited revenue, nominal cash, and accumulated deficits since inception. Management plans to pursue additional funding through debt and equity financing (including the pending 2026 Regulation A+ Offering), enhance operating performance via strategic focus on core products, process efficiencies, and cost structure improvements. There can be no assurance of success in raising working capital or achieving profitable operations, and the financial statements include no adjustments for outcomes of this uncertainty.”
View the 10-Q filed Aug 12, 2026
Market Cap
$21.75M
Shares
494.21M
Volume · Nov 12 385.04K Avg daily vol (3M) 775.53K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $68.38K up 144.3% 10-K filed Mar 31, 2026 Quarterly report FY2026 Q2 Revenue $36.4K up 142.7% 10-Q filed Aug 12, 2026
2026
Nov 5
Current report 8-K Events of Oct 30
Vivos raises $1,000,000 and issues warrants for 25,000,000 shares

Vivos Inc completed a $1,000,000 Regulation A+ offering on October 30, 2026, issuing 12,500,000 common shares, sold warrants for 25,000,000 shares for $25,000 at $.075 per share, and issued 8,000,000 shares for warrant cancellation.

Unregistered sale of equity, Shareholder director nominations, Other events
4 source passages
On October 30, 2026, Vivos Inc. (the “Company”) completed the sale and issuance of 12,500,000 shares of common stock, par value $0.001 per share (“Common Stock”), pursuant to its Regulation A+ offering being conducted on a “best efforts” basis under Regulation A of Section 3(6) of the Securities Act of 1933, as amended (the “Securities Act”) (the “Offering”). The Offering resulted in gross proceeds to the Company of $1,000,000. On October 30, 2026, the Company completed the sale and issuance to certain accredited investors of warrants to purchase 25,000,000 shares of its Common Stock (the “Warrants”), in consideration of an aggregate of $25,000, which warrants expire, if not previously exercised, on December 31, 2030, and are exercisable for Common Stock at $.075 per share. On October 30, 2026, the Company completed the issuance of 8,000,000 shares of Common Stock (the “Exchange Shares”) in consideration for the cancellation of 8,000,000 warrants to purchase shares of Common Stock (the “Warrant Exchange”). Open the document at this passage
Oct 5
Current report 8-K Events of Sep 28
Charter or bylaw amendment, or fiscal year change

Vivos Inc’s Board adopted Series D Convertible Preferred Stock on September 23, 2026; the certificate was filed on September 28, 2026, designating 1.0 million shares with $1.00 stated value, $1.00 liquidation preference and $0.08 conversion price.

Read from the first part of this long document
Aug 12
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $36.4K ▲ 142.7% Net loss $830.19K Diluted EPS $0.00
May 14
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $36.07K ▲ 34.8% Net loss $1.18M Diluted EPS $0.00
Mar 31
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $68.38K ▲ 144.3% Net loss $3.07M Diluted EPS -$0.01
2025
Mar 24
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $4995 Net loss $2.91M Diluted EPS -$0.01
2024
Mar 18
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $19.5K ▼ 46.6% Net loss $2.89M Diluted EPS -$0.01
2023
2022
2021
2020
Showing 1–50 of 51 documents
Key facts CIK 1449349 CUSIP 92858K204 Visit website Investor relations